Montelukast Prescribing at SOUTH PARK SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,100
Total Quantity
33.0K
NHS Cost
£1.6K
vs National Avg
+60.6%
SOUTH PARK SURGERY prescribed 1,100 items of Montelukast over the last 12 months at a cost of £1,568 to the NHS. This is 60.6% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
91
Jul 2026
75
Jul 2026
99
Jul 2026
86
Jul 2026
103
Jul 2026
100
Jul 2026
90
Jul 2026
99
Jul 2026
98
Jul 2026
80
Jul 2026
86
Jul 2026
93
Prescribing Details
| Total Items | 1,100 |
|---|---|
| Total Quantity | 33,012 |
| Total NHS Cost | £1,568 |
| Presentations | 3 different forms |
| vs National Average | +60.6% |
Montelukast Prescribing Comparison
| This practice | 1,100 items |
|---|---|
| National average per practice | 685 items |
| Difference | +60.6% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.